Evidence map›Paper›PMID 36198788›Full record

ArticleNature2022

Antibiotic combinations reduce Staphylococcus aureus clearance.

Viktória Lázár, Olga Snitser, Daniel Barkan, Roy Kishony

Open access · greenAbstract read
In one paragraph

Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. ASP-COMPLEX: redefining antimicrobial stewardship to improve outcomes in high-risk patients with severe infections.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026
    Review
  5. Repurposing Birabresib to target Gram‑positive bacteria.npj antimicrobials and resistance · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Viktória LázárFaculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Olga SnitserFaculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Daniel BarkanKoret School of Veterinary Medicine, The Robert H. Smith Faculty of Agricultural, Food & Environment, The Hebrew University of Jerusalem, Jerusalem, Israel.
Roy KishonyFaculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel. rkishony@technion.ac.il.ORCID http://orcid.org/0000-0002-5013-5072
Technion – Israel Institute of Technology · ILHebrew University of Jerusalem · IL

Funding

The population genetics of antibiotic resistance in multi-drug environmentsR01GM081617 · NIGMS · TECHNION-ISRAEL INSTITUTE OF TECHNOLOGY · PI KISHONY, ROY · 2007 to 2018
$3.7M
European Research Council 281891NIGMS NIH HHS R01 GM081617
6 · The paper itself

Abstract

The spread of antibiotic resistance is attracting increased attention to combination-based treatments. Although drug combinations have been studied extensively for their effects on bacterial growth

Indexed as

Anti-Bacterial AgentsDrug Resistance, MicrobialStaphylococcus aureusbeta-Lactamase Inhibitorsbeta-LactamsDrug CombinationsDrug SynergismHumansMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsStaphylococcal InfectionsAnti-Bacterial Agentsbeta-Lactamase Inhibitorsbeta-LactamsDrug Combinations

Identifiers

PMID36198788
PMCPMC9533972
OpenAlexW4302010917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.